Hepatitis C virus core protein and cellular protein HAX-1 promote 5-fluorouracil-mediated hepatocyte growth inhibition

Journal of Virology

Volumn 83, Issue 19, 2009, Pages 9663-9671

  Banerjee, Arup ^a   Saito, Kousuke ^a   Meyer, Keith ^a   Banerjee, Sutapa ^a   Ait Goughoulte, Malika ^a   Ray, Ratna B ^a   Ray, Ranjit ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 2; CASPASE 7; CORE PROTEIN; FLUOROURACIL; HS1 ASSOCIATED PROTEIN X 1; POLYPROTEIN; PROTEIN P53; PROTEIN X; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DNA LIBRARY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; GROWTH INHIBITION; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LIVER; LIVER CELL; LIVER CELL CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VIRUS GENE; VIRUS VIRULENCE; WESTERN BLOTTING;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; CASPASE 7; CELL LINE, TUMOR; CELL PROLIFERATION; CERCOPITHECUS AETHIOPS; COS CELLS; DNA, COMPLEMENTARY; ENZYME ACTIVATION; FLUOROURACIL; HEPATOCYTES; HUMANS; MICROSCOPY, CONFOCAL; PROTEINS; VIRAL CORE PROTEINS;

HEPATITIS C VIRUS; MAMMALIA;

EID: 70349422338     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00872-09     Document Type: Article

References (42)

1. Basu, A., K. Meyer, R. B. Ray, and R. Ray. 2002. Hepatitis C virus core protein is necessary for the maintenance of immortalized human hepatocyte. Virology 298:53-62. (Pubitemid 34734879)
2. Bunz, F., P. M. Hwang, C. Torrance, T. Waldman, Y. Zhang, L. Dillehay, J. Williams, C., Lengauer, K. W. Kinzler, and B. Vogelstein. 1999. Disruption of p53 in human cancer cells alters the responses to therapeutic agents. J. Clin. Investig. 104:263-269.
3. Gallagher, A. R., A. Cedzich, N. Gretz, S. Somlo, and R. Witzgall. 2000. The polycystic kidney disease protein PKD2 interacts with HAX-1, a protein associated with the actin cytoskeleton. Proc. Natl. Acad. Sci. USA 97:4017-4022.
4. Green, D. R., and J. C. Reed. 1998. Mitochondria and apoptosis. Science 281:1309-1312.
5. Hagiwara, S., M. Kudo, T. Nakatani, Y. Sakaguchi, M. Nagashima, N. Fukuta, M. Kimura, S. Hayakawa, and H. Munakata. 2007. Combination therapy with PEG-IFN-alpha and 5-FU inhibits HepG2 tumour cell growth in nude mice by apoptosis of p53. Br. J. Cancer 97:1532-1537. (Pubitemid 350175847)
6. Han, Y., Y. S. Chen, Z. Liu, N. Bodyak, D. Rigor, E. Bisping, W. T. Pu, and P. M. Kang. 2006. Overexpression of HAX-1 protects cardiac myocytes from apoptosis through caspase-9 inhibition. Circ. Res. 99:415-423.
7. Jiang, Y., W. Zhang, K. Kondo, J. M. Klco, J. M., T. B. St Martin, M. R. Dufault, S. L. Madden, W. G. Kaelin, Jr., and M. Nacht. 2003. Gene expression profiling in a renal cell carcinoma cell line: dissecting VHL and hypoxia-dependent pathways. Mol. Cancer Res. 1:453-462.
8. Johnson, T. M., Z. X. Yu, V. J. Ferrans, R. A. Lowenstein, and T. Finkel. 1996. Reactive oxygen species are downstream mediators of p53-dependent apoptosis. Proc. Natl. Acad. Sci. USA 93:11848-11852.
9. Kanda, T., A. Basu, R. Steele, T. Wakita, J. S. Ryerse, R. Ray, and R. B. Ray. 2006. Generation of infectious hepatitis C virus in immortalized human hepatocytes. J. Virol. 80:4633-4639.
10. Kao, C.-F., S.-Yi. Chen, J.-Y. Chen. and Y.-H. Wu. Lee. 2004. Modulation of p53 transcription regulatory activity and posttranslational modification by hepatitis C virus core protein. Oncogene 23:2472-2483.
11. Kawaguchi, Y., K. Nakajima, M. Igarashi, T. Morita, M. Tanaka, M. Suzuki, A. Yokoyama, G. Matsuda, K. Kato, M. Kanamori, and K. Hirai. 2000. Interaction of Epstein-Barr virus nuclear antigen leader protein (EBNA-LP) with HS1-associated protein X-1: implication of cytoplasmic function of EBNA-LP. J. Virol. 74:10104-10111. (Pubitemid 30780819)
12. Kurokohchi, K., K. Takaguchi, K. Kita, T. Masaki, and S. Kuriyama. 2005. Successful treatment of advanced hepatocellular carcinoma by combined administration of 5-fluorouracil and pegylated interferon-alpha. World J. Gastroenterol. 11:5401-5403.
13. Lauber, K., H. A. Appel, S. F. Schlosser, M. Gregor, K. Schulze-Osthoff, and S. Wesselborg. 2001. The adapter protein apoptotic protease-activating factor-1 (Apaf-1) is proteolytically processed during apoptosis. J. Biol. Chem. 276:29772-29781.
14. Li, W. B., J. Feng, S. M. Geng, P. Y. Zhang, X. N. Yan, G. Hu, C. Q. Zhang, and B. J. Shi. 2009. Induction of apoptosis by Hax-1 siRNA in melanoma cells. Cell Biol. Int. 33:548-554.
15. Lin, Y., W. Ma, and S. Benchimol. 2000. Pidd a new death-domain- containing protein, is induced by p53 and promotes apoptosis. Nature Genet. 26:122-127. (Pubitemid 30692872)
16. Majumder, M., A. K. Ghosh, R. Steele, R. Ray, and R. B. Ray. 2001. Hepatitis C virus NS5A physically associates with p53 and regulates p21/waf1 gene expression in a p53-dependent manner. J. Virol. 75:1401-1407.
17. Mirmohammadsadegh A., U. Tartler, G. Michel, A. Baer, M. Walz, R. Wolf, T. Ruzicka, and U. R. Hengge. 2003. HAX-1, identified by differential display reverse transcription polymerase chain reaction, is overexpressed in lesional psoriasis. J. Investig. Dermatol. 120:1045-1051.
18. Meyer, K., A. Basu, K. Saito, R. B. Ray, and R. Ray. 2005. Inhibition of hepatitis C virus core protein expression in immortalized human hepatocytes induces cytochrome c independent increase in Apaf-1 and caspase-9 activation for cell death. Virology 336:198-207.
19. Oberndorfer, I., D. Schmid, R. Geisberger, G. Achatz-Staussberger, R. Crameri, M. Lamers, and G. Achatz. 2006. HS1-associated protein X-1 interacts with membrane-bound IgE: impact on receptor-mediated internalization. J. Immunol. 177:1139-1145. (Pubitemid 44036617)
20. O'Reilly, L. A., P. Ekert, N. Harvey, V. Marsden, L. Cullen, D. L. Vaux, G. Hacker, C. Magnusson, M. Pakusch, F. Cecconi, K., Kuida, A. Strasser, D. C. Huang, and S. Kumar. 2002. Caspase-2 is not required for thymocyte or neuronal apoptosis even though cleavage of caspase-2 is dependent on both Apaf-1 and caspase-9. Cell Death Differ. 9:832-841.
21. Ota, H., H. Nagano, M. Sakon, H. Eguchi, M. Kondo, T. Yamamoto, M. Nakamura, B. Damdinsuren, H. Wada, S. Marubashi, A. Miyamoto, K. Dono, K. Umeshita, S. Nakamori, K. Wakasa, and M. Monden. 2005. Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-alpha and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expression. Br. J. Cancer 93:557-564. (Pubitemid 43079999)
22. Parker, W. B., and Y. C. Cheng. 1990. Metabolism and mechanism of action of 5-fluorouracil. Pharmacol. Ther. 48:381-395.
23. Polyak, K., Y. Xia, J. L. Zweier, K. Polyak, Y. Xia, and Zweier. 1997. A model for p53-induced apoptosis. Nature 389:300-305.
24. Radhika, V., D. Onesime, J. H. Ha, and N. Dhanasekaran. 2004. Gα13 stimulates cell migration through cortactin-interacting protein HAX-1. J. Biol. Chem. 279:49406-49413.
25. Ray, R. B., K. Meyer, and R. Ray. 2007. Hepatitis C virus core protein promotes immortalization of primary human hepatocytes. Virology 271:193-204.
26. Ray, R. B., and R. Ray. 2001. Hepatitis C virus core protein: intriguing properties and functional relevance. FEMS Microbiol. Lett. 202:149-156.
27. Ray, R. B., R. Steele, K. Meyer, and R. Ray. 1997. Transcriptional repression of p53 promoter by hepatitis C virus core protein. J. Biol. Chem. 272:10983-10986.
28. Remy, I., and S. W. Michnick. 2004. A cDNA library functional screening strategy based on fluorescent protein complementation assays to identify novel components of signaling pathways. Methods 32:381-388. (Pubitemid 38299329)
29. Remy, I., and S. W. Michnick. 2004. Mapping biochemical networks with protein-fragment complementation assays. Methods Mol. Biol. 261:411-426.
30. Robertson, J. D., M. Enoksson, M. Suomela, R. Zhivotovsky, and S. Orrenius. 2002. Caspase-2 acts upstream of mitochondria to promote cytochrome c release during etoposide-induced apoptosis. J. Biol. Chem. 277:29803-29809.
31. Robertson, J. D., V. Gogvadze, A. Kropotov, H. Vakifahmetoglu, R. Zhivotovsky, and S. Orrenius. 2004. Processed caspase-2 can induce mitochondria-mediated apoptosis independently of its enzymatic activity. EMBO Rep. 5:643-648.
32. Shaw, J., and L. A. Kirshenbaum. 2006. HAX-1 represses postmitochondrial caspase-9 activation and cell death during hypoxia-reoxygenation. Circ. Res. 99:336-338.
33. Shikama, Y. U. M., T. Miyashita., and M. Yamada. 2001. Comprehensive studies on subcellular localizations and cell death-inducing activities of eight GFP-tagged apoptosis-related caspases. Exp. Cell Res. 264:315-325.
34. Slee, E. A., M. T. Harte, R. M. Kluck, B. B. Wolf, C. A. Casiano, D. D. Newmeyer, H. G. Wang, J. C. Reed, D. W. Nicholson, E. S. Alnemri, D. R. Green, and S. J. Martin. 1999. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J. Cell Biol. 144:281-292.
35. Suzuki, Y., C. Demoliere, D. Kitamura, H. Takeshita, U. Deuschle, and T. Watanabe. 1997. HAX-1, a novel intracellular protein, localized on mitochondria, directly associates with HS1, a substrate of Src family tyrosine kinases. J. Immunol. 158:2736-2744. (Pubitemid 127470532)
36. Tinel, A., and J. Tschopp. 2004. The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress. Science 304:843-846. (Pubitemid 38620177)
37. Uka, K., H. Aikata, S. Takaki, D. Miki, T. Kawaoka, S. C. Jeong, S. Takahashi, N. Toyota, K. Ito, and K. Chayama. 2007. Pretreatment predictor of response, time to progression, and survival to intraarterial 5-fluorouracil/interferon combination therapy in patients with advanced hepatocellular carcinoma. J. Gastroenterol. 42:845-853. (Pubitemid 47617463)
38. Vafiadaki, E., D. Sanoudou, D. A. Arvanitis, D. H. Catino, E. G. Kranias, and A. Kontrogianni-Konstantopoulos. 2007. Phospholamban interacts with HAX-1, a mitochondrial protein with anti-apoptotic function. J. Mol. Biol. 367:65-79.
39. Vakifahmetoglu, H., M. Olsson, S. Orrenius, and B. Zhivotovsky. 2006. Functional connection between p53 and caspase-2 is essential for apoptosis induced by DNA damage. Oncogene 25:5683-5692. (Pubitemid 44389351)
40. Vayssiere, J. L., P. X. Petit, Y. Risler, and B. Mignotte. 1994. Commitment to apoptosis is associated with changes in mitochondrial biogenesis and activity in cell lines conditionally immortalized with simian virus 40. Proc. Natl. Acad. Sci. USA 91:11752-11756.
41. Velculescu, V. E., L. Zhang, B. Vogelstein, and K. W. Kinzler. 1995. Serial analysis of gene expression. Science 270:484-487.
42. Yamaguchi, H., J. Wyckoff, and J. Condeelis. 2005. Cell migration in tumors. Curr. Opin. Cell Biol. 17:559-564.